The present study demonstrates that ceramides with different acyl chain lengths, generated by CerS2 and CerS6, modulate the ER stress response and SREBP-1 cleavage, which eventually affects hepatic lipogenesis and NAFLD progression. The gene discussed is CERS2; the disease is metabolic dysfunction-associated steatotic liver disease.